Peter MD vs Skinny.Rx

Peter MD is a men's health telehealth platform that treats erectile dysfunction, low testosterone, and weight loss through GLP-1 medications. The service holds a 4.4/5 rating on Trustpilot and accepts HSA and FSA payments, making it one of the more flexible options for covering treatment costs. Peter MD also offers a price match guarantee, which sets it apart from many direct-to-consumer telehealth brands.

Skinny.Rx takes a narrower approach, focusing only on GLP-1 weight loss medications like compounded semaglutide and tirzepatide. The platform serves all adults nationwide and carries an 8.5/10 rating from over 4,378 reviews, with plans starting at $149 per month. By concentrating on a single category, Skinny.Rx aims to make GLP-1 access faster and more affordable than broader telehealth services.

The core difference comes down to scope. Peter MD treats several men's health conditions under one account, while Skinny.Rx serves anyone seeking weight loss support regardless of gender. Telehealth use has grown significantly since 2020, with the CDC reporting that 37% of adults used telemedicine in a recent survey year, according to CDC data on telemedicine use.

Peter MD prices ED medications starting at $1.50 per dose for generic sildenafil or tadalafil, which is competitive with the lowest-cost telehealth ED options available. Testosterone therapy and GLP-1 weight loss pricing varies based on dosage and protocol, and Peter MD's price match guarantee means you can request matching if you find a lower verified price elsewhere. HSA and FSA cards are accepted, which can reduce out-of-pocket costs depending on your tax bracket.

Skinny.Rx starts at $149 per month for compounded GLP-1 medications, which typically includes the medication, provider consultation, and ongoing support. This pricing sits in the mid-range for compounded semaglutide and tirzepatide telehealth services, where monthly costs commonly run from $150 to $400 depending on dose escalation. Branded GLP-1s like Wegovy and Zepbound list at over $1,000 per month before insurance, so compounded alternatives can offer meaningful savings.

If you're paying with HSA or FSA funds, Peter MD's acceptance of these accounts is worth noting since not every telehealth service supports them. According to IRS Publication 502, prescription medications and weight loss treatments tied to a specific medical condition can qualify as eligible medical expenses. Always check with your plan administrator before assuming a service will reimburse.

Peter MD offers a broader medication menu, including sildenafil and tadalafil for ED, testosterone replacement therapy formulations, and GLP-1 receptor agonists for weight loss. Sildenafil and tadalafil are FDA-approved generics with decades of safety data behind them, and tadalafil's longer half-life of about 17.5 hours allows for more flexible dosing compared to sildenafil's 4-hour window. The FDA originally approved sildenafil in 1998, as documented in FDA approval records.

Skinny.Rx focuses on compounded semaglutide and tirzepatide, the same active ingredients found in Ozempic, Wegovy, Mounjaro, and Zepbound. In the SURMOUNT-1 trial published in the New England Journal of Medicine, participants taking tirzepatide 15mg lost an average of 20.9% of their body weight over 72 weeks, as reported in NEJM clinical trial data. Compounded versions are not FDA-approved but can be legally produced by licensed compounding pharmacies under specific conditions.

Testosterone therapy through Peter MD involves lab testing and ongoing monitoring, since exogenous testosterone affects red blood cell counts, lipid profiles, and fertility. The Endocrine Society recommends confirming low testosterone with two morning blood draws before starting therapy, a guideline that responsible telehealth providers should follow. Skinny.Rx does not offer testosterone or ED treatment, so men seeking those alongside weight loss would need a separate provider.

Both Peter MD and Skinny.Rx use an asynchronous telehealth model where you complete an intake form, a licensed provider reviews your information, and medication ships from a partner pharmacy if approved. Peter MD's process for testosterone therapy includes lab work, which is required to diagnose hypogonadism according to clinical guidelines from the NIH National Library of Medicine. Without lab confirmation, testosterone prescribing falls outside accepted standards of care.

Skinny.Rx's process is streamlined for GLP-1 access, typically involving a medical questionnaire, photo or video verification, and provider review without requiring labs in many cases. Some weight loss telehealth services do request baseline labs to screen for thyroid issues or pancreatitis risk, so it's worth asking what's included before signing up. Ongoing support usually involves messaging with a care team and dose adjustment guidance over time.

Side effect monitoring matters with both services. ED medications can cause headaches, flushing, and rare visual changes, while GLP-1s commonly cause nausea, vomiting, and constipation, particularly during dose escalation. The FDA has documented these reactions in postmarketing surveillance, with semaglutide labeling noting gastrointestinal events in up to 44% of trial participants per FDA prescribing information.

Peter MD makes the most sense if you're a man dealing with multiple health concerns at once, like ED plus weight gain or low energy plus interest in testosterone therapy. Having one provider handle several prescriptions can simplify follow-up and reduce the hassle of managing accounts across multiple telehealth services. The HSA/FSA acceptance and price match guarantee also benefit anyone watching costs closely.

Skinny.Rx is better suited if your only goal is weight loss and you want a service focused entirely on GLP-1 medications. The narrow focus often translates to faster intake, more competitive monthly pricing, and a care team that specializes in weight management coaching. Women seeking GLP-1 treatment also need an alternative to Peter MD, since that brand serves men only.

Obesity affects more than 40% of US adults according to CDC obesity statistics, and access to GLP-1 medications has expanded significantly through telehealth. If you don't need ED or testosterone treatment, paying for a men's health platform doesn't add value over a focused weight loss service. The right choice depends on whether you want one-stop care or a specialist.

Peter MD wins on breadth, offering ED, testosterone, and GLP-1 weight loss under a single men's health account with HSA/FSA support and a price match guarantee. The 4.4/5 Trustpilot rating reflects generally positive feedback, and starting prices of $1.50 per dose for ED generics are among the lowest in the category. The trade-off is that Peter MD only serves men.

Skinny.Rx wins on focus and accessibility, serving any adult nationwide with compounded semaglutide and tirzepatide starting at $149 per month. The 8.5/10 rating across 4,378 reviews suggests consistent satisfaction among weight loss customers, and the specialized focus may translate to better support for GLP-1 specific questions. Compounded GLP-1 access has filled gaps during ongoing branded medication shortages tracked by the FDA Drug Shortages database.

Neither service is universally better, the right pick depends on what you're treating and who you are. A man with ED and weight loss goals gets more value from Peter MD's combined offering. A woman or man whose only need is GLP-1 treatment will likely find Skinny.Rx more efficient and cost-effective.